The influencing factors of renal response in newly diagnosed multiple myeloma patients with renal impairment

被引:0
|
作者
宋宇航 [1 ]
机构
[1] Dept Hematol,PUMC & CAMS
关键词
D O I
暂无
中图分类号
R733.3 [骨髓肿瘤]; R692 [肾疾病];
学科分类号
摘要
Objective To investigate the causative factors of renal function in newly diagnosed multiple myeloma(MM) patients with renal inadequacy.Methods 181MM patients with renal impairment from August 2007 to October 2021 at Peking Union Medical College Hospital were recruited,whose baseline chronic kidney disease(CKD) stage was 3-5.Statistical analysis was performed based on laboratory tests,treatment regimens,hematological responses,and survival among various renal function efficacy groups.A logistic regression model was employed in multivariate analysis.Results A total of 181 patients were recruited,and 277 patients with CKD stages 1-2 were chosen as controls.The majority were chosen according to the BCD and VRD regimens.The progression-free survival(PFS)(14.0 months vs24.8 months,P <0.001) and overall survival(OS)(49.2 months vs 79.7 months,P <0.001) of patients with renal impairment was considerably shorter.
引用
收藏
页码:119 / 119
页数:1
相关论文
共 50 条
  • [21] Prognostic impact of renal failure recovery in patients with newly diagnosed multiple myeloma
    Pena, Camila
    Valladares, Ximena
    Gajardo, Claudia
    Russo, Moises
    Morales, Alvaro
    Correa, Gonzalo
    Valjalo, Ricardo
    REVISTA MEDICA DE CHILE, 2019, 147 (11) : 1374 - 1381
  • [22] Carfilzomib Is Safe and Effective in Newly Diagnosed Patients with Multiple Myeloma with Renal Involvement
    Diamond, Benjamin
    Jayabalan, David S.
    Pearse, Roger
    Perry, Art
    Pekle, Karen
    Niesvizky, Ruben
    Rossi, Adriana C.
    BLOOD, 2017, 130
  • [23] Renal Response of Selinexor, Pomalidomide, Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients with Renal Impairment: A Prospective, Open-Label, Multicenter, Phase 2 Study
    Zhou, Huixing
    Chang, Long
    Jia, Jing
    Ma, Jie
    Xue, Hua
    Li, Hao
    Huang, Wenrong
    Zhou, Hebing
    Sun, Jingnan
    Su, Liping
    Ma, Yanping
    Huang Hongming
    Jing, Hongmei
    Li, Zhenling
    Ma, Guangyu
    Su, Guohong
    Zhou, Jihao
    Chen, Biyun
    Bao, Li
    Zhang, Zhihua
    BLOOD, 2023, 142
  • [24] SIGNIFICANT IMPROVEMENT IN RENAL FUNCTION IN NEWLY DIAGNOSED MULTIPLE MYELOMA
    Ismail, I.
    Saponara, A.
    Mantha, M.
    Bavishi, K.
    Dheda, S.
    NEPHROLOGY, 2018, 23 : 69 - 69
  • [25] The Role of Novel Agents on Reversibility of Renal Impairment in Newly Diagnosed Patients with Multiple Myeloma; a Single Center Experience on 112 Patients
    Dimopoulos, Meletios A.
    Roussou, Maria
    Gkotzamanidou, Maria
    Psimenou, Erasmia
    Mparmparoussi, Despoina
    Matsouka, Charis
    Terpos, Evangelos
    Kastritis, Efstathios
    BLOOD, 2011, 118 (21) : 1694 - 1694
  • [26] Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma
    W I Gonsalves
    N Leung
    S V Rajkumar
    A Dispenzieri
    M Q Lacy
    S R Hayman
    F K Buadi
    D Dingli
    P Kapoor
    R S Go
    Y Lin
    S J Russell
    J A Lust
    S Zeldenrust
    R A Kyle
    M A Gertz
    S K Kumar
    Blood Cancer Journal, 2015, 5 : e296 - e296
  • [27] Improvement in Renal Function and Its Impact on Survival in Patients with Newly Diagnosed Multiple Myeloma
    Gonsalves, Wilson I.
    Leung, Nelson
    Rajkumar, S. Vincent
    Dispenzieri, Angela
    Buadi, Francis
    Lacy, Martha Q.
    Dingli, David
    Kapoor, Prashant
    Go, Ronald S.
    Lust, John A.
    Hayman, Suzanne R.
    Lin, Yi
    Zeldenrust, Steven R.
    Kyle, Robert A.
    Gertz, Morie A.
    Kumar, Shaji
    BLOOD, 2014, 124 (21)
  • [28] Renal insufficiency predicts worse prognosis in newly diagnosed IgD multiple myeloma patients
    Yan, Ge
    Li, Huangmin
    Zhang, Yiding
    Xia, Chenyan
    Wang, Mengxiao
    Jia, Yu
    Shang, Jin
    Zhao, Zhanzheng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [29] Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents
    Roussou, Maria
    Kastritis, Efstathios
    Christoulas, Dimitrios
    Migkou, Magdalini
    Gavriatopoulou, Maria
    Grapsa, Irini
    Psimenou, Erasmia
    Gika, Dimitra
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    LEUKEMIA RESEARCH, 2010, 34 (10) : 1395 - 1397
  • [30] Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma
    Gonsalves, W. I.
    Leung, N.
    Rajkumar, S. V.
    Dispenzieri, A.
    Lacy, M. Q.
    Hayman, S. R.
    Buadi, F. K.
    Dingli, D.
    Kapoor, P.
    Go, R. S.
    Lin, Y.
    Russell, S. J.
    Lust, J. A.
    Zeldenrust, S.
    Kyle, R. A.
    Gertz, M. A.
    Kumar, S. K.
    BLOOD CANCER JOURNAL, 2015, 5 : e296 - e296